Rodent models of glaucoma and their applicability for drug discovery

Expert Opin Drug Discov. 2017 Mar;12(3):261-270. doi: 10.1080/17460441.2017.1281244. Epub 2017 Jan 18.

Abstract

Rodents have widely been used to represent glaucomatous changes both in the presence and absence of elevated intraocular pressure (IOP) as they offer clear advantages over other animal species. IOP elevation is commonly achieved by creating an obstruction in the aqueous outflow pathways, consequently leading to retinal ganglion cell and optic nerve (ON) damage, the hallmark of glaucoma. These changes may also be achieved in the absence of elevated IOP by directly inflicting injury to retina or ON. Areas covered: This paper presents a summary of currently used rodent models of glaucoma. The characteristics of these models from several studies are summarized. The benefits and shortcomings of these models are also discussed. Expert opinion: The choice of animal model that closely represents human disease is key for successful translational of preclinical research to clinical practice. Rodent models of rapid IOP elevation are likely to be least representative, whereas models such as steroid-induced glaucoma models more closely resemble the trabecular meshwork changes seen in glaucomatous human eyes. However, this model needs further characterization. Rodent models based on direct retinal and ON injury are also useful tools to investigate molecular mechanisms involved at the site of final common pathology and neuroprotective strategies.

Keywords: Glaucoma models; intraocular pressure; optic nerve; retinal ganglion cells; rodents.

Publication types

  • Review

MeSH terms

  • Animals
  • Disease Models, Animal*
  • Drug Discovery / methods*
  • Glaucoma / complications
  • Glaucoma / drug therapy
  • Glaucoma / pathology*
  • Humans
  • Intraocular Pressure
  • Neuroprotective Agents / therapeutic use
  • Optic Nerve / pathology
  • Retinal Ganglion Cells / pathology
  • Species Specificity
  • Translational Research, Biomedical / methods

Substances

  • Neuroprotective Agents